LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 805

Search options

  1. Book ; Online ; E-Book: Abdominal sepsis

    Sartelli, Massimo / Bassetti, Matteo / Martin-Loeches, Ignacio

    a multidisciplinary approach

    (Hot topics in acute care surgery and trauma)

    2018  

    Author's details Massimo Sartelli, Matteo Bassetti, Ignacio Martin-Loeches editors
    Series title Hot topics in acute care surgery and trauma
    Keywords Medicine ; Medical microbiology ; Critical care medicine ; Infectious diseases ; Abdominal surgery ; Traumatology
    Subject code 617.55059
    Language English
    Size 1 Online-Ressource (XI, 405 Seiten), Illustrationen
    Publisher Springer
    Publishing place Cham
    Publishing country Switzerland
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT019691110
    ISBN 978-3-319-59704-1 ; 9783319597034 ; 3-319-59704-3 ; 3319597035
    DOI 10.1007/978-3-319-59704-1
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article ; Online: Too many antibiotics for patients with COVID-19 despite low bacterial infections.

    Giacobbe, Daniele Roberto / Bassetti, Matteo

    The Lancet. Infectious diseases

    2023  Volume 23, Issue 6, Page(s) 636–637

    MeSH term(s) Humans ; COVID-19/microbiology ; Anti-Bacterial Agents/therapeutic use ; Bacterial Infections/drug therapy ; Bacterial Infections/microbiology ; SARS-CoV-2
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2023-01-27
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(22)00866-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Book ; Online: Punteggio EQUAL Scedosporiosi/Lomentosporiosi 2021

    Stemler, Jannik / Lackner, Michaela / Chen, Shuang / Hoenigl, Martin / Cornely, Oliver Andreas / Bassetti, Matteo

    un punteggio ECMM basato sulle attuali linee guida per misurare la QUALità della gestione clinica della Scedosporiosi/Lomentosporiosi

    (EQUAL Scedosporiosis/Lomentosporiosis Scorecard)

    2022  

    Abstract: Il punteggio EQUAL Scedosporiosi/Lomentosporiosi pondera e raggruppa i diversi fattori per la gestione ottimale della scedosporiosi e della lomentosporiosi. I punteggi riflettono le più solide raccomandazioni delle linee guida attuali. Le schede di ... ...

    Institution Universitätsklinikum Köln / Klinik I für Innere Medizin
    Author's details Jannik Stemler, Michaela Lackner, Sharon Chen, Martin Hoenigl, Oliver A. Cornely, Matteo Bassetti ; Uniklinik Köln, Medical University of Graz, The University of Sydney, Medizinische Universität Innsbruck
    Series title EQUAL Scedosporiosis/Lomentosporiosis Scorecard
    Abstract Il punteggio EQUAL Scedosporiosi/Lomentosporiosi pondera e raggruppa i diversi fattori per la gestione ottimale della scedosporiosi e della lomentosporiosi. I punteggi riflettono le più solide raccomandazioni delle linee guida attuali. Le schede di punteggio EQUAL sono un riferimento rapido per quantificare l'aderenza alle linee guida e per sostenere la stewardship antifungina.
    Subject code 610
    Language Italian
    Size 1 Online-Ressource (2 Blätter)
    Publisher Uniklinik Köln
    Publishing place Köln
    Publishing country Germany
    Document type Book ; Online
    HBZ-ID HT021471802
    DOI 10.4126/FRL01-006401914
    Database Repository for Life Sciences

    Kategorien

  4. Article ; Online: An introduction to the future of echinocandin therapy.

    Bassetti, Matteo

    The Journal of antimicrobial chemotherapy

    2018  Volume 73, Issue suppl_1, Page(s) i2–i3

    Language English
    Publishing date 2018-01-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 191709-2
    ISSN 1460-2091 ; 0305-7453
    ISSN (online) 1460-2091
    ISSN 0305-7453
    DOI 10.1093/jac/dkx443
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Update on skin and soft tissue infections.

    Bassetti, Matteo

    Current opinion in infectious diseases

    2018  Volume 31, Issue 2, Page(s) 103

    Language English
    Publishing date 2018-01-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 645085-4
    ISSN 1473-6527 ; 1535-3877 ; 0951-7375 ; 1355-834X
    ISSN (online) 1473-6527 ; 1535-3877
    ISSN 0951-7375 ; 1355-834X
    DOI 10.1097/QCO.0000000000000444
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Response to: "the impact of age, disease severity, and vaccination status on antibiotic use in hospitalized patients with COVID-19".

    Bassetti, Matteo / Brucci, Giorgia / Vena, Antonio / Giacobbe, Daniele Roberto

    Expert opinion on pharmacotherapy

    2024  Volume 24, Issue 18, Page(s) 2229–2230

    MeSH term(s) Humans ; COVID-19 ; Patient Acuity ; Vaccination ; Anti-Bacterial Agents/therapeutic use
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2024-01-05
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 2001535-5
    ISSN 1744-7666 ; 1465-6566
    ISSN (online) 1744-7666
    ISSN 1465-6566
    DOI 10.1080/14656566.2023.2270419
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Innovative β-lactam/β-lactamase inhibitor combinations for carbapenem-resistant Gram-negative bacteria.

    Giacobbe, Daniele R / Bassetti, Matteo

    Future microbiology

    2022  Volume 17, Page(s) 393–396

    MeSH term(s) Anti-Bacterial Agents/pharmacology ; Carbapenems/pharmacology ; Cefepime/pharmacology ; Drug Combinations ; Gram-Negative Bacteria ; Lactams ; Microbial Sensitivity Tests ; beta-Lactamase Inhibitors/pharmacology ; beta-Lactamases/genetics
    Chemical Substances Anti-Bacterial Agents ; Carbapenems ; Drug Combinations ; Lactams ; beta-Lactamase Inhibitors ; Cefepime (807PW4VQE3) ; beta-Lactamases (EC 3.5.2.6)
    Language English
    Publishing date 2022-03-02
    Publishing country England
    Document type Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2254620-0
    ISSN 1746-0921 ; 1746-0913
    ISSN (online) 1746-0921
    ISSN 1746-0913
    DOI 10.2217/fmb-2021-0301
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Skin and soft tissue infections due to rapidly growing mycobacteria.

    Sepulcri, Chiara / Vena, Antonio / Bassetti, Matteo

    Current opinion in infectious diseases

    2023  Volume 36, Issue 2, Page(s) 74–80

    Abstract: Purpose of review: The aim of this article is to review skin and soft tissue infections due to rapidly growing mycobacteria (RGM), with a particular focus on recently published literature (2021-2022).: Recent findings: RGM are increasingly reported ... ...

    Abstract Purpose of review: The aim of this article is to review skin and soft tissue infections due to rapidly growing mycobacteria (RGM), with a particular focus on recently published literature (2021-2022).
    Recent findings: RGM are increasingly reported as a cause of skin and soft tissue infections, both in the community setting and as a cause of nosocomial outbreaks. Recent advances in molecular methods have expanded the number of species of RGM and resulted in increased diagnosis. New treatment options are under evaluation particularly for Mycobacterium abscessus , the most difficult-to-treat among RGM.
    Summary: RGM are an uncommon cause of skin and soft tissue infections and a high clinical suspicion together with advanced laboratory facilities are required for diagnosis. Species identification and antimicrobial susceptibility testing are essential to drive appropriate treatment, which combines surgical debridement with prolonged antimycobacterial combination therapy.
    MeSH term(s) Humans ; Soft Tissue Infections/diagnosis ; Soft Tissue Infections/drug therapy ; Mycobacterium ; Mycobacterium Infections, Nontuberculous/diagnosis ; Mycobacterium Infections, Nontuberculous/drug therapy ; Anti-Bacterial Agents/therapeutic use ; Skin/microbiology ; Microbial Sensitivity Tests
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2023-01-30
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 645085-4
    ISSN 1473-6527 ; 1535-3877 ; 0951-7375 ; 1355-834X
    ISSN (online) 1473-6527 ; 1535-3877
    ISSN 0951-7375 ; 1355-834X
    DOI 10.1097/QCO.0000000000000905
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The safety of ceftolozane/tazobactam for the treatment of complicated urinary tract infections.

    Bassetti, Matteo / Vena, Antonio / Giacobbe, Daniele Roberto

    Expert opinion on drug safety

    2023  Volume 22, Issue 7, Page(s) 533–540

    Abstract: Introduction: Ceftolozane is a cephalosporin similar to ceftazidime in its structure, which is marketed in combination with tazobactam, a well-known β-lactamase inhibitor.: Areas covered: After a brief introduction on the drug characteristics and ... ...

    Abstract Introduction: Ceftolozane is a cephalosporin similar to ceftazidime in its structure, which is marketed in combination with tazobactam, a well-known β-lactamase inhibitor.
    Areas covered: After a brief introduction on the drug characteristics and efficacy, we focused on available data from randomized controlled trials and post-marketing observational studies pertaining to the safety of ceftolozane/tazobactam (C/T) for the treatment of complicated urinary tract infections (cUTI). A search was conducted in PubMed from January 2010 to February 2023.
    Expert opinion: The use of C/T for the treatment of cUTI is supported by solid efficacy and safety data, especially for the treatment of those pathogens where it can represent a first-line approach due to some peculiar characteristics: (i) treatment of cUTI caused by multidrug-resistant
    MeSH term(s) Humans ; Anti-Bacterial Agents/adverse effects ; Tazobactam/adverse effects ; Cephalosporins/adverse effects ; Urinary Tract Infections/drug therapy ; Urinary Tract Infections/chemically induced ; Carbapenems
    Chemical Substances ceftolozane (37A4IES95Q) ; Anti-Bacterial Agents ; ceftolozane, tazobactam drug combination ; Tazobactam (SE10G96M8W) ; Cephalosporins ; Carbapenems
    Language English
    Publishing date 2023-07-03
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2088728-0
    ISSN 1744-764X ; 1474-0338
    ISSN (online) 1744-764X
    ISSN 1474-0338
    DOI 10.1080/14740338.2023.2227085
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Management of nonfermenting gram-negative infections: a critique of the guidelines.

    Bassetti, Matteo / Vena, Antonio / Giacobbe, Daniele Roberto

    Current opinion in infectious diseases

    2023  Volume 36, Issue 6, Page(s) 609–614

    Abstract: Purpose of review: In the present narrative review, we discuss the characteristics and differences between the Infectious Diseases Society of America (IDSA) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines in ... ...

    Abstract Purpose of review: In the present narrative review, we discuss the characteristics and differences between the Infectious Diseases Society of America (IDSA) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines in terms on their recommendations/suggestions for the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii infections.
    Recent findings: Treatment of severe infections caused by nonfermenting gram-negative bacteria (NF-GNB) is posing both novel hopes and novel challenges to physicians worldwide, and both the IDSA and the ESCMID have recently updated/released their guidelines or guidance documents, based on different philosophies and providing recommendations for the treatment of NF-GNB infections. In order to correctly exploit recent advances in the treatment of such infections, IDSA and ESCMID approaches should be viewed as complementary and evolving, and should not preclude further revision based on accumulating evidence on the use of novel β-lactams and β-lactam/β-lactamase inhibitor combinations.
    Summary: A joint consideration of both philosophies should leave the door opened for the wise use of novel agents, ultimately building precious experience on their use that could favorably influence future guidelines revisions.
    MeSH term(s) Humans ; Anti-Bacterial Agents/therapeutic use ; Anti-Bacterial Agents/pharmacology ; Gram-Negative Bacteria ; beta-Lactamase Inhibitors/therapeutic use ; beta-Lactams/therapeutic use ; Acinetobacter Infections/drug therapy ; Monobactams/therapeutic use ; Communicable Diseases
    Chemical Substances Anti-Bacterial Agents ; beta-Lactamase Inhibitors ; beta-Lactams ; Monobactams
    Language English
    Publishing date 2023-09-28
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 645085-4
    ISSN 1473-6527 ; 1535-3877 ; 0951-7375 ; 1355-834X
    ISSN (online) 1473-6527 ; 1535-3877
    ISSN 0951-7375 ; 1355-834X
    DOI 10.1097/QCO.0000000000000982
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top